Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OrtopadUSA is the U.S. commercial brand and retail presence for ORTOPAD adhesive occlusion eye patches used in pediatric vision care. The business sells hypo-allergenic, latex-free eye patches, including bamboo-based variants, designed to support amblyopia therapy and strabismus-related occlusion treatment in children. Its products are marketed as fun, patterned patches intended to improve adherence to patching regimens, and are offered in multiple pediatric sizes and packaging formats. The website indicates that OrtopadUSA operates as a division of Optego Vision USA, suggesting it is a branded commercial business unit rather than a standalone drug-development biotech company. Overall, this is a healthcare-related commercial ophthalmic products business focused on eye-care supplies, not a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OrtopadUSA.